Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 17, 13:30
468.55
2.4 (0.51%)
VOLUME 130,927
LIVE
NSE
Apr 17, 12:17
466.75
0.65 (0.14%)
VOLUME 543,925
Business News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Glenmark pulls 2,900 bottles of ulcer drug in US

2.32 pm | 18 Apr 2014 |  Source: Reuters

Medicines produced in India, which supplies about 40 percent of generic and over-the-counter drugs sold in the United States, have come under increase...

Lupin pulls over 9,000 bottles of anti-infective Suprax

2.16 pm | 15 Apr 2014 |  Source: Reuters

The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year b...

Sun to make Rs 18cr open offer to Zenotech shareholders

10.29 pm | 11 Apr 2014 |  Source: PTI

Through the open offer, Sun Pharma plans to acquire more than 96 lakh shares of Zenotech, amounting to 28.1 percent. The price would be Rs 19 per shar...

Crisil reaffirms 'A1+' rating on Ranbaxy's bank facilities

9.23 pm | 09 Apr 2014 |  Source: PTI

The ratings continue to reflect Ranbaxy's established position in the international generics market and in the Indian formulations market. The rating ...

Sun plans gradual phase-out of Ranbaxy-branded drugs in US

7.20 pm | 09 Apr 2014 |  Source: Reuters

Uday Baldota, Sun Pharma's senior vice president of finance and accounts, didn't comment directly when asked whether Sun Pharma will phase out Ranbaxy...

Exports to EU from Ranbaxy's two plants to remain suspended

6.55 pm | 09 Apr 2014 |  Source: PTI

The European Medicines Agency (EMA) said that Indian authorities have withdrawn certification to the Toansa plant, while an international inspection o...

Sebi gets complaints on Ranbaxy share trade before merger

6.41 pm | 09 Apr 2014 |  Source: PTI

Securities and Exchange Board of India has started collating data related to the matter from stock exchanges and clearing corporations, sources said....

No ground for insider trading charges against Sun: Shanghvi 

5.17 pm | 09 Apr 2014 |  Source: CNBC-TV18

Dilip Shanghvi believes post the deal, Sun Pharma will keep the Ranbaxy brand alive and will work towards boosting the company's margins, significantl...

Brokers' group to ask SEBI to probe Ranbaxy trades

2.55 pm | 09 Apr 2014 |  Source: Reuters

The president of an Indian brokerage association is planning to formally request that India's market regulator investigate trading in Ranbaxy Laborato...

CCI nod for Sun-Ranbaxy deal likely in 6 months: KK Sharma 

2.37 pm | 09 Apr 2014 |  Source: CNBC-TV18

On Holcim – Lafarge, Sharma says India will be one of the markets where the companies' "scheme of divestiture will be needed"....

Can Sun Pharma defy law of averages on M&A deal trend?

12.49 pm | 09 Apr 2014 |  Source: Moneycontrol.com

So far, the only effective setback received by Sun Pharma is its plan to acquire a 100 percent stake in Taro, in 2010, which did not succeed....

Sun chairman Makov confident of turning around Ranbaxy 

11.57 am | 09 Apr 2014 |  Source: CNBC-TV18

The 75-year-old Israel Makov, the former chief of Teva Pharma, is a respected figure in international corporate circles and his experience would come ...

Despite cultural issues, see no biz disruptions: Sun Pharma 

4.42 pm | 07 Apr 2014 |  Source: CNBC-TV18

Uday Baldota, Senior Vice President - Finance & Accounts, Sun Pharma talks to CNBC-TV18’s Menaka Doshi and Senthil Chengalvarayan about the steps in...

Ranbaxy is good, cheap buy by Sun Pharma: Kewal Handa 

4.02 pm | 07 Apr 2014 |  Source: CNBC-TV18

Handa, who currently serves as chairman of Medybiz Pharma, said that this deal will be a big positive for Ranbaxy shareholders...

Sun may review Ranbaxy's portfolio: Pharmasianews 

2.24 pm | 07 Apr 2014 |  Source: CNBC-TV18

Vikas Dandekar thinks that Sun may review and trim Ranbaxy’s portfolio to avoid duplication....

Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.